Your browser doesn't support javascript.
loading
SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine.
Kotaki, Ryutaro; Adachi, Yu; Moriyama, Saya; Onodera, Taishi; Fukushi, Shuetsu; Nagakura, Takaki; Tonouchi, Keisuke; Terahara, Kazutaka; Sun, Lin; Takano, Tomohiro; Nishiyama, Ayae; Shinkai, Masaharu; Oba, Kunihiro; Nakamura-Uchiyama, Fukumi; Shimizu, Hidefumi; Suzuki, Tadaki; Matsumura, Takayuki; Isogawa, Masanori; Takahashi, Yoshimasa.
Afiliação
  • Kotaki R; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Adachi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Moriyama S; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Onodera T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Fukushi S; Department of Virology I, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Nagakura T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Tonouchi K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Terahara K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Sun L; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Takano T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Nishiyama A; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Shinkai M; Tokyo Shinagawa Hospital, Tokyo 140-8522, Japan.
  • Oba K; Department of Pediatrics, Showa General Hospital, Tokyo 187-8510, Japan.
  • Nakamura-Uchiyama F; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo 130-8575, Japan.
  • Shimizu H; Department of Respiratory Medicine, JCHO Tokyo Shinjuku Medical Center, Tokyo 162-0821, Japan.
  • Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Matsumura T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Isogawa M; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Takahashi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Sci Immunol ; 7(70): eabn8590, 2022 04 22.
Article em En | MEDLINE | ID: mdl-35113654
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Sci Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Sci Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão